Charles Schwab Investment Management Inc Maxcyte, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 291,980 shares of MXCT stock, worth $975,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
291,980
Previous 299,673
2.57%
Holding current value
$975,213
Previous $1.17 Million
4.21%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$31.2 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$27.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$18.1 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$16.8 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$14.7 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $340M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...